UK dementia organisations publish new manifesto ahead of general election
The manifesto calls on the next UK government to make dementia a key health priority
Read More
Tag: Alzheimer’s Research UK
New study reveals neurological conditions as leading cause of ill health worldwide
In 2021, neurological conditions, including Alzheimer’s disease, affected approximately 3.4 billion people globally
Read More
Oxford University to develop Alzheimer’s disease treatments with Exscientia
Exscientia will use its AI-driven technology to generate novel clinical assets targeting neuroinflammation
Read More
Charity forms Alzheimer’s disease taskforce
Alzheimer’s Research UK is calling on the NHS and the pharma industry to join its new taskforce to ensure people with dementia can access future treatments without unnecessary delay.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
